glp1 medication tirzepatide People Can Lose Their Zest for Life After Starting GLP-1s, Docs Warn FDA says shortage of GLP-1

Beyond managing blood sugar, GLP-1 agonists have shown cardiovascular benefits

Patients with inflammatory bowel disease, diverticular disease, or hemorrhoids should be monitored closely for symptom changes

Administered by SC injection, it's generally well-tolerated but has risks

Behavioral interventions alone rarely achieve more than 5-10% sustained weight loss, while tirzepatide consistently produces 15-23% reduction in clinical trials

These drugs mimic hormones that reduce appetite, slow digestion, and regulate blood sugar

Individuals with borderline diagnoses: If your lab numbers have been trending in the wrong direction, whether for blood sugar, blood pressure, cholesterol, or hemoglobin A1C, your doctor may have described a borderline issue to you